DEBIRI

DEVICE2 trials

Sponsors

Yale University, Singapore General Hospital

Conditions

Colorectal CancerColorectal Cancer Metastatic

Phase 1

Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI).

CompletedNCT02350400

Singapore General HospitalColorectal Cancer Metastatic

Start: 2014-06-30End: 2016-02-29Updated: 2017-02-14

Phase 2

Irinotecan -Eluting LC Bead-M1 (DEBIRI-M1) for Patients With Liver Metastases From Colorectal Cancer

CompletedNCT02015754

Yale UniversityColorectal Cancer

Start: 2014-02-28End: 2016-12-13Updated: 2018-03-22